Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

ViroMed

ViroMed
1996 FOUNDED
PUBLIC STATUS
101-200 EMPLOYEES
084990 STOCK SYMBOL
1 INVESTMENTS
$84.65 SHARE PRICE (As of Friday Closing)
Description

Helixmith Co Ltd, formerly ViroMed Co Ltd is active in the healthcare sector in Korea. The company specializes in developing pharmaceutical products for the treatment of diseases related to peripheral artery, coronary artery, cardiovascular system and neuropathy, cancer and allergy. Its suite of products includes protein/deoxyribonucleic acid (DNA)-based biopharmaceuticals, botanical drugs and natural pharmaceuticals.

Formerly Known As
ViroMedica Pacific
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Drug Discovery
Stock Exchange
KRX
Primary Office
  • 5th Floor, Building 203, SNU
  • No. 599 Gwanak-ro, Gwanak-gu
  • Seoul, 151-747
  • South Korea
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore ViroMed’s full profile, request a free trial.

ViroMed Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$53.49 - $220.64 $1.8B $83.78 -$1.20 1.34M 21.3M

ViroMed Financials Summary

In Thousands,
USD
TTM
30-Jun-2019
FY 2018
31-Dec-2018
FY 2017
31-Dec-2017
FY 2016
31-Dec-2016
Enterprise Value 2,370,008 3,591,715 2,431,078 1,220,264
Revenue 4,549 4,805 2,785 5,874
EBITDA (24,162) (27,713) (6,821) (512)
Net Income (24,384) (26,138) (5,728) (613)
Total Assets 261,321 254,166 167,867 147,325
Total Debt 101,085 73,212 10,657 3,860
Public Fundamental Data provided by Morningstar, Inc. disclaimer

ViroMed Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore ViroMed‘s full profile, request access.

Request full access to PitchBook

ViroMed Investments (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000 (000 0000000 20-Aug-2018 000000000 00000 00 Buildings and Property 00000000 000 00.0
To view this company’s complete investment and acquisition history, request access »

ViroMed Executive Team (4)

Name Title Board
Seat
Contact
Info
Yongsoo Kim President & Chief Executive Officer
Sunyoung Kim Ph.D Co-Founder & Chief Scientific Officer, Research & Development Center
Sungchul Kim Co-Founder, Board Member, Chief Financial Officer & Director, Management Support Division
Jong-Mook Kim Ph.D Co-Founder, Director, Development Division & Strategic Business Division & Board Member

ViroMed Board Members (2)

Name Representing Role Since Contact
Info
Jong-Mook Kim Ph.D ViroMed Co-Founder, Director, Development Division & Strategic Business Division & Board Member 000 0000
Sungchul Kim ViroMed Co-Founder, Board Member, Chief Financial Officer & Director, Management Support Division 000 0000